Dr. Shaheen Kavoussi, MD

Dr. Kavoussi practices at Victoria Eye Center in Victoria, Texas.

Dr. Kavoussi's NPI, 1063788446, was assigned on March 29, 2012. Dr. Kavoussi graduated from Baylor College Of Medicine in 2010. Dr. Kavoussi holds Texas license Q4439.

Dr. Kavoussi's primary practice is Victoria Eye Center, at 107 James Coleman Dr, Victoria, TX 77904 in Victoria County. The practice phone is (361) 578-0234.

Dr. Kavoussi's primary practice is Victoria Eye Center in Victoria, Texas. Dr. Kavoussi is also affiliated with Houston Methodist Hospital. The medical group on file is UTHealth Houston Neurosciences, Texas Medical Center. Dmand AI also links Dr. Kavoussi to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kavoussi practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Kavoussi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Kavoussi is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Kavoussi's licenses on file in 4 states: Texas, California, Indiana and New York.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Kavoussi treats.

CMS data shows 7,054 Medicare services from Dr. Kavoussi across 21 procedure codes in 2024, for 493 Medicare patients. Medicare paid $1,500,505 for them.

CMS counts 493 Medicare patients who saw Dr. Kavoussi in 2024. The largest group is 65 to 74, with 195 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kavoussi's median patient age at 72, with 53% women.

In 2024, Dr. Kavoussi wrote 434 Medicare Part D claims for 163 patients. 58% of them were for generic drugs. CMS names the drug for 374 of them, across 6 drugs with 11 or more claims each, at $10,031 in total drug cost. In 2023, CMS named 453 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kavoussi for performance year 2024, reported individually. Dr. Kavoussi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Kavoussi, published from 2011 to 2015. 2015 was the busiest year, with 10. The most frequent topics are Acrylic Resins, Lenses, Intraocular and Lens Implantation, Intraocular. Dr. Kavoussi has published most often in J Cataract Refract Surg. Dr. Kavoussi's most frequent co-authors are Nick Mamalis, MD, Stanley R. Fuller, MD and Mark L. Hill, MD.

CMS Open Payments shows 637 general payments to Dr. Kavoussi from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $313,461.

Dr. Kavoussi graduated from Baylor College Of Medicine in 2010.

Dr. Kavoussi is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.